当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
COAGADEX, Coagulation Factor X (Human)
申请企业
Bio Products Laboratory
药品名称
COAGADEX, Coagulation Factor X (Human)
承诺描述
A post-marketing registry study of perioperative management of moderate to severe hereditary factor X deficient patients receiving Coagadex (human factor X concentrate) for major surgical procedures.
报告接收日期
2020/12/22 0:00:00